Cannabis and Epilepsy Panel

The following videos were created by the Epilepsy Foundation to provide information to medical professionals about epilepsy, cannabis, and cannabidiol (a substance in cannabis).

The videos are hosted by Editor-In-Chief Joseph I. Sirven MD and feature our Medications Editor Barry Gidal PharmD, our Medical Cannabis Editor Anup Patel MD, our Government Relations Manager Abbey Roudebush Esq., and our Associate Editor Patty Osborne Shafer RN, MN.

Thank You

The Epilepsy Foundation is grateful for the support of an unrestricted educational grant from Greenwich Biosciences.

The Epilepsy Foundation is solely responsible for the creation, editorial oversight, and management of these videos.


A History’s contributors talk about the history of medical cannabis in the treatment of epilepsy, including a primer on terminology and the botany of the cannabis plant.

Joining’s editors and staff in this video is Alice Mead, head of U.S. public policy and public affairs for Greenwich Biosciences.

Efficacy and Current Studies’s contributors talk about studies conducted on cannabis and cannabidiol, including what has been learned about its effectiveness for treating Dravet and Lennox-Gastaut syndromes, contraindications, interactions with other medications, response rates, and side effects, as well as whether information from clinical studies can be applied to other epilepsy syndromes and dispensary versions of cannabis-related products.

Pharmacotherapeutics’s contributors help practitioners understand the pharmacotherapeutics of cannabidiol in the treatment of epilepsy, including what studies have shown about side effects, potential benefits, interactions, how it is metabolized, dosing for children and adults, and how to monitor and manage this treatment option.


Counseling with Families’s contributors - including a pharmacist, epileptologist, and nurse - have practical advice and guidance for medical practitioners with questions about using cannabis in the treatment of patients with difficult to control seizures.


Legal Considerations’s contributors discuss the practical issues related to using and prescribing cannabidiol, the Epilepsy Foundation’s position on medical cannabis, guidance for practitioners, navigating federal and state laws, differences in products available at dispensaries and by prescription, and resources for medical professionals.


Regulatory Considerations’s contributors discuss regulatory considerations and processes for medications, including licensing, oversight, access, and differences in various products.


Reviewed By: 
Joseph I. Sirven MD | Patty Osborne Shafer RN, MN
Thursday, November 15, 2018